Development of a photocleavable PEG-maleimide band-shift assay for S-nitrosylated apolipoprotein E in human cerebrospinal fluid
Analytical Biochemistry · 2027-02 · 721 · 116292
DOI: 10.1016/j.ab.2026.116292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2027-02. Verfasst von Wakana Iinuma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Protein S-nitrosylation is a redox modification implicated in neurodegenerative diseases. However, the functional significance of S-nitrosylated apolipoprotein E (apoE-SNO), a key lipid transport protein in the central nervous system, remains poorly understood. We developed a photocleavable polyethylene glycol-maleimide (PEG-Mal)-based band-shift assay to detect apoE-SNO and examined its applicability in human cerebrospinal fluid (CSF) samples. Free cysteine thiols were blocked with N-ethylmaleimide, followed by the selective reduction of S-nitrosothiols with ascorbate and labeling of the newly generated thiols with PEG-Mal. PEG-Mal labeling produced a characteristic molecular weight shift in non-reducing SDS-PAGE, enabling apoE-SNO detection by immunoblotting with an anti-apoE antibody after electrophoretic separation and UV-mediated cleavage of the PEG moiety. Optimization using S-nitrosylated recombinant apoE and plasma samples showed that 3 mM N-ethylmaleimide effectively blocked free thiols, whereas 50 mM ascorbate allowed efficient S-nitrosothiol reduction without reducing disulfide-linked apoE. The specificity of the assay was supported by ascorbate-dependent labeling, the disappearance of the shifted band after UV pre-irradiation, and a concentration-dependent increase in the apoE-SNO signal in response to S-nitrosoglutathione. The limit of detection for apoE-SNO was 58 μg/L, with reliable relative signal comparison observed above 175 μg/L. Preliminary analysis of human CSF samples showed variable apoE-SNO signals among representative cases, with differences observed between patients within the same diagnostic category, supporting the feasibility of applying this assay to clinically relevant specimens. This assay provides a visually interpretable analytical approach for detecting apoE-SNO and may provide a basis for studies on apoE redox status in CSF and other biological samples.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
- Department of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan; Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
- Department of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan; Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan; Department of Biomedi…
Zitieren
APA
Iinuma, W., Uematsu, Y., Kinoshita, I., Matsuura, H., Shimizu, R., & Yamauchi, K. (2027). Development of a photocleavable PEG-maleimide band-shift assay for S-nitrosylated apolipoprotein E in human cerebrospinal fluid. Analytical Biochemistry, 721, 116292. https://doi.org/10.1016/j.ab.2026.116292
Vancouver
Iinuma W, Uematsu Y, Kinoshita I, Matsuura H, Shimizu R, Yamauchi K. Development of a photocleavable PEG-maleimide band-shift assay for S-nitrosylated apolipoprotein E in human cerebrospinal fluid. Analytical Biochemistry. 2027;721:116292. doi:10.1016/j.ab.2026.116292
BibTeX
@article{Iinuma2027,
author = {Iinuma, Wakana and Uematsu, Yui and Kinoshita, Ikumi and Matsuura, Hiroto and Shimizu, Riho and Yamauchi, Kazuyoshi},
title = {Development of a photocleavable PEG-maleimide band-shift assay for S-nitrosylated apolipoprotein E in human cerebrospinal fluid},
journal = {Analytical Biochemistry},
year = {2027},
volume = {721},
pages = {116292},
doi = {10.1016/j.ab.2026.116292}
}
EUVIMED